Coty edges past quarterly revenue estimates on international fragrances demand

Coty (COTY.N) shares fell 12% after the company forecast a 6-8% decline in current-quarter like-for-like sales, attributing the weak outlook to persistent U.S. consumer caution and tariff impacts on demand for its beauty products. This negative forecast overshadowed a Q4 revenue beat and an adjusted quarterly loss, reflecting broader industry challenges from tightening consumer spending and weak travel retail, as also seen with Estee Lauder. Coty aims to mitigate these headwinds through new product launches in the second half of the fiscal year and by transferring some production to domestic plants.

Analysis

Coty's projection of a 6% to 8% like-for-like sales decline for the current quarter marks a significant deterioration from the 4.5% growth a year ago, triggering a 12% drop in its shares and signaling severe near-term headwinds. This pessimistic guidance overshadowed a fourth-quarter revenue beat, where sales fell 8% to $1.25 billion but still surpassed the $1.20 billion estimate. The core issues are multi-faceted, stemming from cautious U.S. consumer spending, retailer destocking, and the impact of tariffs, which are industry-wide pressures also reflected in peer Estee Lauder's weak forecast. Compounding the issue, Coty reported an adjusted loss of 5 cents per share, missing consensus estimates for a profit, and recorded a substantial $212.8 million non-cash asset impairment charge in its color cosmetics business, highlighting persistent demand weakness. The company's turnaround strategy is heavily reliant on a second-half recovery driven by new product launches in its prestige fragrance category, targeting wealthier consumers, and a plan to onshore manufacturing to mitigate tariff impacts.

Key Decisions for Investors

• Given the sharply negative Q1 sales forecast and significant earnings miss, investors should anticipate continued stock price volatility and reassess exposure due to heightened near-term downside risk.
• The viability of a second-half recovery depends critically on the success of new product launches; monitor initial sales data for prestige fragrances like Burberry Goddess and the upcoming Hugo Boss line as key performance indicators.
• Note that the headwinds are industry-wide, and the $212.8 million impairment charge in color cosmetics signals a deep-seated weakness that may persist beyond the current quarter, warranting caution on the segment's recovery prospects.